Complete the form below to access this guide to sequencing epigenetic modifications. Epigenetics is the study of chemical ...
Alzheimer’s disease (AD) remains one of the most pressing neurodegenerative disorders worldwide, characterized by progressive memory loss, synaptic ...
The COVID-19 pandemic gave us tremendous perspective on how wildly symptoms and outcomes can vary between patients ...
By selectively blocking the ATAC complex via its unique YEATS2 subunit, a new inhibitor turns off tumor-promoting genes, ...
A research team has made a breakthrough in epigenetic drug discovery. The researchers have successfully developed a ...
People could soon live to 150 years as breakthroughs in biological clocks and rejuvenation research stretch human lifespans ...
Scribe expects to initiate a first-in-human hypercholesterolemia study in mid-2026 with STX-1150, its lead cardiometabolic assetSTX-1150 is designed to deliver durable therapeutic LDL-C lowering with ...
The COVID-19 pandemic gave us tremendous perspective on how wildly symptoms and outcomes can vary between patients ...
Using single-cell epigenomic profiling of immune cells from 110 individuals, researchers show that genetic variation and ...
Researchers developed LS-170, an inhibitor of the ATAC complex, which suppressed oncogene expression and reduced tumor growth ...
In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results